Why is fair value unavailable for XOMA Corp (NASDAQ-XOMA) stock?

A reliable fair value estimate is not currently available for XOMA Corp (NASDAQ-XOMA). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

What is the P/E ratio for XOMA Corp (NASDAQ-XOMA)?

The current P/E ratio listed for XOMA Corp (NASDAQ-XOMA) is 35.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of XOMA Corp?

The current market capitalization listed for XOMA Corp is 710.2 M.

What is the ticker symbol for XOMA Corp?

The ticker symbol for XOMA Corp is NASDAQ-XOMA, and the stock is listed on NASDAQ.

Where is XOMA Corp (NASDAQ-XOMA) listed?

XOMA Corp (NASDAQ-XOMA) is listed on NASDAQ.

What is the debt-to-total-capital ratio for XOMA Corp?

The current debt-to-total-capital ratio listed for XOMA Corp is 14.6%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for XOMA Corp?

The free float listed for XOMA Corp is 7.0%. Free float helps investors understand how much of the share base is available for public trading.

XOMA Corp (XOMA) Fair Value & Stock Analysis

XOMA Corp (XOMA)

XOMA Corp is a NASDAQ-listed common stock of a healthcare company focused on biotechnology royalty investments. Through its operating business, the company holds economic rights tied to future milestone and royalty payments from partnered therapeutic candidates, including assets in pre-commercial and commercial stages. Its portfolio spans early- to mid-stage clinical programs, primarily in Phase 1 and Phase 2, as well as late-stage clinical and marketed assets. XOMA also seeks to acquire milestone and royalty revenue streams linked to partnered development programs. The company was originally incorporated in 1981 and is based in Emeryville, California. It operated previously under the name XOMA Corporation and adopted the XOMA Royalty Corporation name in July 2024.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NASDAQ-XOMA	Not available	Not available	Not available	35.6x	7.7x	14.6x	710.2 M	14.6%	7.0%	-4.1	16.4%	34.1%